Clinical trial
Developing Rumination-focused Treatment to Reduce Risk for Depression Recurrence (RDR) in Adolescence
NCT03859297 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Rumination-focused Treatment to Reduce Risk for Depression Recurrence (RDR) in Adolescence
- Lead sponsor
- Ohio State University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 1, 2019
- Completion date
- March 2, 2029
- Enrollment
- 183 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.